{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:24:38Z","timestamp":1761110678791,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cpcardiol.2023.102125","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T02:08:24Z","timestamp":1696558104000},"page":"102125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PC","title":["Safety and Efficacy of Ferric Carboxymaltose in Heart Failure With Preserved Ejection Fraction and Iron Deficiency"],"prefix":"10.1016","volume":"49","author":[{"given":"Hassan","family":"Shabeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseer","family":"Samore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umer Riaz","family":"Gondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badar U. Din","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7303-2484","authenticated-orcid":false,"given":"Maria","family":"Faraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahanzeb","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.102125_bib0001","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.hfc.2017.02.005","article-title":"Heart failure with preserved ejection fraction in older adults","volume":"13","author":"Upadhya","year":"2017","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.709872","article-title":"Iron deficiency: a new target for patients with heart failure","volume":"8","author":"Rizzo","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl I","key":"10.1016\/j.cpcardiol.2023.102125_bib0003","doi-asserted-by":"crossref","first-page":"I96","DOI":"10.1093\/eurheartjsupp\/suac080","article-title":"Iron deficiency in heart failure: diagnosis and clinical implications","volume":"24","author":"Del Pinto","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0004","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1002\/ehf2.13146","article-title":"Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis","volume":"7","author":"Khan","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0006","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/jcm11010125","article-title":"Iron deficiency in heart failure: mechanisms and pathophysiology","volume":"11","author":"Alnuwaysir","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0008","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","article-title":"Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets","volume":"132","author":"Sawicki","year":"2023","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.102125_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0010","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.ijcard.2013.07.185","article-title":"Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction","volume":"168","author":"Kasner","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.102125_bib0011","first-page":"340","article-title":"The cardiomyopathy of iron deficiency","volume":"33","author":"Hegde","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0012","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bjhh.2015.08.012","article-title":"Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia","volume":"37","author":"Friedrisch","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/172104","article-title":"Safety and efficacy of intravenous ferric carboxymaltose (750\u2009mg) in the treatment of iron deficiency anemia: two randomized, controlled trials","volume":"2012","author":"Barish","year":"2012","journal-title":"Anemia"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0014","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/DDDT.S55499","article-title":"Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose","volume":"8","author":"Toblli","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.102125_bib0015","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J Res Med Sci"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.102125_bib0016","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anemia","volume":"69","author":"Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0017","doi-asserted-by":"crossref","unstructured":"Vikrant S, Parashar A. The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: a single center study. Indian J Nephrol.;25:213-21. doi: 10.4103\/0971-4065.144421.","DOI":"10.4103\/0971-4065.144421"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-Vilella","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0019","doi-asserted-by":"crossref","unstructured":"Huguet JM, Cort\u00e9s X, Bosc\u00e1-Watts MM, et\u00a0al. Ferric carboxymaltose improves the quality of life of patients with inflammatory bowel disease and iron deficiency without anaemia. J Clin Med;11:2786. doi: 10.3390\/jcm11102786.","DOI":"10.3390\/jcm11102786"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0020","first-page":"176","article-title":"Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases","volume":"18","author":"Salvadori","year":"2020","journal-title":"Blood Transfus"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/728952","article-title":"Safety and efficacy of ferric carboxymaltose in anemic pregnant women: a retrospective case control study","volume":"2015","author":"Pels","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0022","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1111\/jog.14956","article-title":"Clinical effects and safety of ferric carboxymaltose in pregnancy: an Indian real-life experience","volume":"47","author":"Gupte","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/169107","article-title":"Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia","volume":"2013","author":"Hussain","year":"2013","journal-title":"Anemia"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0024","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","article-title":"Hepcidin regulation in the anemia of inflammation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0025","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.15420\/cfr.2021.26","article-title":"The effect of iron deficiency on cardiac function and structure in heart failure with reduced ejection fraction","volume":"8","author":"Martens","year":"2022","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0026","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCULATIONAHA.121.054271","article-title":"Intravenous iron therapy in heart failure with reduced ejection fraction: tackling the deficiency","volume":"144","author":"Sawicki","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0027","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.2478","article-title":"Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency","volume":"24","author":"Butler","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0028","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ihj.2017.10.009","article-title":"Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: a meta-analysis","volume":"69","author":"Dalal","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0029","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JBM.S361210","article-title":"Efficacy and safety of ferric carboxymaltose in the management of iron deficiency anemia: a multi-center real-world study from India","volume":"13","author":"Charmila","year":"2022","journal-title":"J Blood Med"},{"key":"10.1016\/j.cpcardiol.2023.102125_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40256-016-0211-2","article-title":"Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners","volume":"17","author":"Drozd","year":"2017","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062300542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:49:15Z","timestamp":1758941355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014628062300542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S014628062300542X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102125","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Ferric Carboxymaltose in Heart Failure With Preserved Ejection Fraction and Iron Deficiency","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102125"}}